New NHS Guide Warns on Botox and Mental Health Disorders

The topic gained prominence following the publication of draft guidance from the National Institute for Health and Care Excellence (NICE), which proposes that doctors, dentists, and dermatologists screen patients for obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD) who wish to undergo cosmetic procedures, such as botox.

What the New NICE Guidance Requires

According to the document, professionals providing aesthetic services must ask structured questions about appearance-related concerns before performing any intervention. If the answers indicate a risk of OCD or BDD, the patient should be referred to a specialist, and the procedure may be suspended.

Why Screening is Important

The guide highlights that individuals with OCD exhibit obsessive thoughts and repetitive behaviors, while those with BDD spend a lot of time preoccupied with perceived physical flaws. Both disorders can be exacerbated by cosmetic interventions that reinforce a distorted body perception.

Statistics on OCD and BDD

Estimates indicate that about 1.2% of the population suffers from OCD, and approximately 2% have BDD. These figures underscore the need to identify such cases before appearance-altering procedures.

Expert Reactions to the Draft

Eric Power, interim director of NICE's Centre for Guidelines, states that these disorders are often misunderstood and that early identification can prevent patients from waiting until a crisis point to receive appropriate support. The guidance also recommends that professionals consider assessing patients with anxiety or depression for OCD and BDD.

Expected Impact on Clinical Practice

By normalizing the discussion around intrusive thoughts, images, or doubts related to appearance, the new guidance aims to reduce stigma and improve access to appropriate treatment. The proposal is expected to come into effect next year, after final review.

With information from The Telegraph, The Sun, The Independent.